Cyber-criminals often see healthcare firms’ shoddy protection as a “pot of gold.”
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
While virtual care boomed during the pandemic, the sector more recently had an up-and-down couple of years as the world returned to normalcy.
Moderna is counting on revenue from newer mRNA vaccines, including a next generation Covid shot, to make up for falling sales.
One high-profile early adopter: Swiss bank UBS, which is turning its army of investment banking analysts into AI avatars.
Just over 70% of Americans say they don’t want to live to be centenarians, afraid they won’t be able to afford the costs of longevity.
US President Donald Trump is reportedly considering linking prescription drug prices to their price tags in other developed nations.
“There’s just so many ways you can leverage that data, and it’s relatively easy to get.”
The allegations highlight third-party software risks.
Tech firms are seeking patents for AI-powered medical devices.
Behind the blinding white light of Monday’s trillion–dollar AI wipeout that was a spot of unabashedly good AI news.
Some 8,000 industry movers and shakers are expected today for the annual JPMorgan Healthcare Conference, or simply JPM.
Novo Nordisk reported earnings, posting some chunky year-over-year growth and far outperforming its only real rival at the moment, Eli Lilly.
Walmart announced on Tuesday that it’s introducing a new same-day delivery service for prescription medication.
The leadership change comes as the retail pharmacy industry faces thin profit margins, store closures, and layoffs.
A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half.
Bausch + Lomb has stirred up significant interest from the pair of private equity giants, TPG and Blackstone.